NCT06756542 Evaluating the Use of Artificial Intelligence to Improve Family Conversations for Intensive Care Patients and Their Families
| NCT ID | NCT06756542 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Davy van de Sande |
| Condition | Intensive Care Medicine |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-01-14 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-01-14 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study looks at how artificial intelligence (AI), like generative pre-trained transformer (GPT-4), can help doctors in the intensive care unit (ICU) save time and improve communication with families. Right now, doctors spend a lot of time writing notes after family conversations, which takes time away from patient care. The investigators are testing whether AI can create accurate and easy-to-understand summaries of these conversations, making it quicker for doctors to document and clearer for families to understand. ICU doctors and adult family members of patients will take part in this study, with their full consent. The goal is to see if this new technology can make life easier for doctors while helping families better understand medical information.
Eligibility Criteria
Inclusion Criteria: * Informed-consent is signed by all participating family members during the conversation. * Informed-consent is signed by the ICU healthcare professionals. * The patient of the family must be admitted to the adult ICU. * All participating family members must be 18 years or older. * The family conversation must be in Dutch. Exclusion Criteria: * Trained to interpret medical jargon and/or intensive care terminology specifically * Difficulty reading and/or writing in the Dutch language
Contact & Investigator
Diederik Gommers, MD PhD
STUDY DIRECTOR
Intensive Care Adults, Erasmus University Medical Center, Rotterdam, the Netherlands
Frequently Asked Questions
Who can join the NCT06756542 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intensive Care Medicine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06756542 currently recruiting?
Yes, NCT06756542 is actively recruiting participants. Contact the research team at d.sande@erasmusmc.nl for enrollment information.
Where is the NCT06756542 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands, Rotterdam, Netherlands.
Who is sponsoring the NCT06756542 clinical trial?
NCT06756542 is sponsored by Davy van de Sande. The principal investigator is Diederik Gommers, MD PhD at Intensive Care Adults, Erasmus University Medical Center, Rotterdam, the Netherlands. The trial plans to enroll 40 participants.